Tolazamide
- TRADE NAMES: Diabewas; Diadutos; Norglycin; Tolanase; Tolinase (Pfizer); Tolisan
- INDICATIONS: Non-insulin dependent diabetes Type II
- CLASS: Antidiabetic, Hypoglycemic (antihyperglycemic) agent, Sulfonylurea
- HALF-LIFE: 7 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Phenylbutazones
PREGNANCY CATEGORY: C
Tolazamide is a sulfonamide and can be absorbed systemically. Sulfonamides can produce severe, possibly fatal, reactions such as toxic epidermal necrolysis and Stevens-Johnson syndrome.
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
GASTROINTESTINAL/HEPATIC.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric